Spine includes pedicle screws, interbody cages, cervical and lumbar plates, expandable cages, motion-preserving cervical disc replacements, and enabling technologies (navigation, robotics, augmented reality). Products include fusion implants, interbody cages, biologics, motion preservation devices and navigation systems. Payer scrutiny is high, and coverage often requires documented conservative treatment first. Surgeon training and clinical outcomes data shape adoption.

Why it matters

Mature segment with significant ASC migration. Enabling technology bundles (Mako Spine, ExcelsiusGPS, NuVasive Pulse) are the primary differentiator beyond hardware.

Common pitfalls

•A common pitfall is underestimating the clinical data requirements for novel spine devices, leading to delays in market access.
•Failing to adequately address cybersecurity risks for enabling technologies, like navigation or robotic systems, can result in regulatory non-compliance.
•Ignoring the post-market surveillance obligations for long-term implantable devices, which often require extensive data collection, is a frequent mistake.
•Inadequate validation of software used in surgical planning or robotic guidance can lead to regulatory scrutiny.
•Not correctly classifying combination products, such as drug-eluting spinal implants, can result in an incorrect regulatory pathway.

Sources

NASS · NASS
AdvaMed - Industry Reports · AdvaMed
MedTech Europe - Facts & Figures · MedTech Europe
FDA Office of Orthopedic Devices: Division of Spinal Devices · FDA

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.